Skip to main content
Top
Published in: Archives of Virology 7/2012

01-07-2012 | Original Article

Construction of an infectious clone of human adenovirus type 41

Authors: Duo-Ling Chen, Liu-Xin Dong, Meng Li, Xiao-Juan Guo, Min Wang, Xin-Feng Liu, Zhuo-Zhuang Lu, Tao Hung

Published in: Archives of Virology | Issue 7/2012

Login to get access

Abstract

Human adenovirus type 41 (HAdV-41) is well known for its fastidiousness in cell culture. To construct an infectious clone of HAdV-41, a DNA fragment containing the left and right ends of HAdV-41 as well as a kanamycin resistance gene and a pBR322 replication origin was excised from the previously constructed plasmid pAd41-GFP. Using homologous recombination, the plasmid pKAd41 was generated by co-transformation of the E. coli BJ5183 strain with this fragment and HAdV-41 genomic DNA. Virus was rescued from pKAd41-transfected 293TE7 cells, a HAdV-41 E1B55K–expressing cell line. The genomic integrity of the rescued virus was verified by restriction analysis and sequencing. Two fibers on the virion were confirmed by western blot. Immunofluorescence showed that more expression of the hexon protein could be found in 293TE7 cells than in 293 cells after HAdV-41 infection. The feature of non-lytic replication was preserved in 293TE7 cells, since very few progeny HAdV-41 viruses were released to the culture medium. These results show that pKAd41 is an effective infectious clone and suggest that the combination of pKAd41 and 293TE7 cells is an ideal system for virological study of HAdV-41.
Literature
1.
go back to reference Albinsson B, Kidd AH (1999) Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res 64:125–136PubMedCrossRef Albinsson B, Kidd AH (1999) Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res 64:125–136PubMedCrossRef
2.
go back to reference Brown M, Wilson-Friesen HL, Doane F (1992) A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture. J Virol 66:3198–3205PubMed Brown M, Wilson-Friesen HL, Doane F (1992) A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture. J Virol 66:3198–3205PubMed
3.
go back to reference Croyle MA, Stone M, Amidon GL, Roessler BJ (1998) In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther 5:645–654PubMedCrossRef Croyle MA, Stone M, Amidon GL, Roessler BJ (1998) In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther 5:645–654PubMedCrossRef
4.
go back to reference Davis AR, Wilson JM (1996) Vectors for gene therapy (adenoviral vectors). John Wiley, New York Davis AR, Wilson JM (1996) Vectors for gene therapy (adenoviral vectors). John Wiley, New York
5.
go back to reference Davison AJ, Telford EA, Watson MS, McBride K, Mautner V (1993) The DNA sequence of adenovirus type 40. J Mol Biol 234:1308–1316PubMedCrossRef Davison AJ, Telford EA, Watson MS, McBride K, Mautner V (1993) The DNA sequence of adenovirus type 40. J Mol Biol 234:1308–1316PubMedCrossRef
6.
go back to reference Favier AL, Burmeister WP, Chroboczek J (2004) Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology 322:93–104PubMedCrossRef Favier AL, Burmeister WP, Chroboczek J (2004) Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology 322:93–104PubMedCrossRef
7.
go back to reference Hart LS, Ornelles D, Koumenis C (2007) The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage. J Biol Chem 282:6061–6067PubMedCrossRef Hart LS, Ornelles D, Koumenis C (2007) The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage. J Biol Chem 282:6061–6067PubMedCrossRef
8.
go back to reference He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514PubMedCrossRef He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514PubMedCrossRef
9.
go back to reference Hirt B (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26:365–369PubMedCrossRef Hirt B (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26:365–369PubMedCrossRef
10.
go back to reference Kidd AH, Cosgrove BP, Brown RA, Madeley CR (1982) Faecal adenoviruses from Glasgow babies. Studies on culture and identity. J Hyg (Lond) 88:463–474CrossRef Kidd AH, Cosgrove BP, Brown RA, Madeley CR (1982) Faecal adenoviruses from Glasgow babies. Studies on culture and identity. J Hyg (Lond) 88:463–474CrossRef
11.
go back to reference Kidd AH, Chroboczek J, Cusack S, Ruigrok RW (1993) Adenovirus type 40 virions contain two distinct fibers. Virology 192:73–84PubMedCrossRef Kidd AH, Chroboczek J, Cusack S, Ruigrok RW (1993) Adenovirus type 40 virions contain two distinct fibers. Virology 192:73–84PubMedCrossRef
12.
go back to reference Kim M, Lim MY, Ko G (2010) Enhancement of enteric adenovirus cultivation by viral transactivator proteins. Appl Environ Microbiol 76:2509–2516PubMedCrossRef Kim M, Lim MY, Ko G (2010) Enhancement of enteric adenovirus cultivation by viral transactivator proteins. Appl Environ Microbiol 76:2509–2516PubMedCrossRef
13.
go back to reference Kuo J (2007) Electron Microscopy: methods and protocols. Humana Press, USA Kuo J (2007) Electron Microscopy: methods and protocols. Humana Press, USA
14.
go back to reference Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC (1998) E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 140:637–645PubMedCrossRef Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC (1998) E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 140:637–645PubMedCrossRef
15.
go back to reference Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR, Gall JG (2007) Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine 25:2074–2084PubMedCrossRef Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR, Gall JG (2007) Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine 25:2074–2084PubMedCrossRef
16.
go back to reference Li L, Phan TG, Nguyen TA, Kim KS, Seo JK, Shimizu H, Suzuki E, Okitsu S, Ushijima H (2005) Molecular epidemiology of adenovirus infection among pediatric population with diarrhea in Asia. Microbiol Immunol 49:121–128PubMed Li L, Phan TG, Nguyen TA, Kim KS, Seo JK, Shimizu H, Suzuki E, Okitsu S, Ushijima H (2005) Molecular epidemiology of adenovirus infection among pediatric population with diarrhea in Asia. Microbiol Immunol 49:121–128PubMed
17.
go back to reference Liu HY, Han BJ, Zhong YX, Lu ZZ (2009) A three-plasmid system for construction of armed oncolytic adenovirus. J Virol Methods 162:8–13PubMedCrossRef Liu HY, Han BJ, Zhong YX, Lu ZZ (2009) A three-plasmid system for construction of armed oncolytic adenovirus. J Virol Methods 162:8–13PubMedCrossRef
18.
go back to reference Lu ZZ, Zou XH, Dong LX, Qu JG, Song JD, Wang M, Guo L, Hung T (2009) Novel recombinant adenovirus type 41 vector and its biological properties. J Gene Med 11:128–138PubMedCrossRef Lu ZZ, Zou XH, Dong LX, Qu JG, Song JD, Wang M, Guo L, Hung T (2009) Novel recombinant adenovirus type 41 vector and its biological properties. J Gene Med 11:128–138PubMedCrossRef
19.
go back to reference Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ (1998) The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 72:7909–7915PubMed Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ (1998) The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 72:7909–7915PubMed
20.
go back to reference Sherwood V, Burgert HG, Chen YH, Sanghera S, Katafigiotis S, Randall RE, Connerton I, Mellits KH (2007) Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation. J Gen Virol 88:71–76PubMedCrossRef Sherwood V, Burgert HG, Chen YH, Sanghera S, Katafigiotis S, Randall RE, Connerton I, Mellits KH (2007) Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation. J Gen Virol 88:71–76PubMedCrossRef
21.
go back to reference Subramanian T, Vijayalingam S, Chinnadurai G (2006) Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol 80:2000–2012PubMedCrossRef Subramanian T, Vijayalingam S, Chinnadurai G (2006) Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol 80:2000–2012PubMedCrossRef
22.
23.
go back to reference Tollefson AE, Ryerse JS, Scaria A, Hermiston TW, Wold WS (1996) The E3–11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220:152–162PubMedCrossRef Tollefson AE, Ryerse JS, Scaria A, Hermiston TW, Wold WS (1996) The E3–11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220:152–162PubMedCrossRef
24.
go back to reference Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ, Wold WS (1996) The adenovirus death protein (E3–11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol 70:2296–2306PubMed Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ, Wold WS (1996) The adenovirus death protein (E3–11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol 70:2296–2306PubMed
25.
go back to reference Yamasaki S, Miura Y, Brown E, Davydova J, Yamamoto M (2010) Development of a method for effective amplification of human adenovirus 40. Arch Virol 155:1059–1068PubMedCrossRef Yamasaki S, Miura Y, Brown E, Davydova J, Yamamoto M (2010) Development of a method for effective amplification of human adenovirus 40. Arch Virol 155:1059–1068PubMedCrossRef
26.
go back to reference Yeh HY, Pieniazek N, Pieniazek D, Gelderblom H, Luftig RB (1994) Human adenovirus type 41 contains two fibers. Virus Res 33:179–198PubMedCrossRef Yeh HY, Pieniazek N, Pieniazek D, Gelderblom H, Luftig RB (1994) Human adenovirus type 41 contains two fibers. Virus Res 33:179–198PubMedCrossRef
27.
go back to reference Yeh HY, Pieniazek N, Pieniazek D, Luftig RB (1996) Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41. J Virol 70:2658–2663PubMed Yeh HY, Pieniazek N, Pieniazek D, Luftig RB (1996) Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41. J Virol 70:2658–2663PubMed
28.
go back to reference Zou XH, Xiao X, Chen DL, Li ZL, Song JD, Wang M, Qu JG, Lu ZZ, Hung T (2011) An improved HAdV-41 E1B55K-expressing 293 cell line for packaging fastidious adenovirus. J Virol Methods 175:188–196PubMedCrossRef Zou XH, Xiao X, Chen DL, Li ZL, Song JD, Wang M, Qu JG, Lu ZZ, Hung T (2011) An improved HAdV-41 E1B55K-expressing 293 cell line for packaging fastidious adenovirus. J Virol Methods 175:188–196PubMedCrossRef
Metadata
Title
Construction of an infectious clone of human adenovirus type 41
Authors
Duo-Ling Chen
Liu-Xin Dong
Meng Li
Xiao-Juan Guo
Min Wang
Xin-Feng Liu
Zhuo-Zhuang Lu
Tao Hung
Publication date
01-07-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1293-z

Other articles of this Issue 7/2012

Archives of Virology 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.